Literature DB >> 6294678

Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain.

R Quirion, M A Bayorh, R L Zerbe, C B Pert.   

Abstract

Chronic phencyclidine treatment (10 mg/kg/day, SC for 14 days) significantly decreased the number of [3H]phencyclidine and [3H]spiperone binding sites in rat brain. [3H]Dihydromorphine binding was not affected by the same treatment. An acute treatment with phencyclidine (10 mg/kg, SC) did not modify any of the binding sites under study. These results suggest that a chronic phencyclidine treatment induces a down-regulation of phencyclidine and dopamine receptors without affecting opiate receptors. These reductions in the number of phencyclidine and dopamine binding sites might be related to the development of tolerance and/or dependence to phencyclidine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294678     DOI: 10.1016/0091-3057(82)90349-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  1 in total

1.  Inhibition of calcium ATPase by phencyclidine in rat brain.

Authors:  M Pande; J A Cameron; P J Vig; S F Ali; D Desaiah
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.